Arzneimittel aus Blut, rekombinant und Gentherapie

Hospices Civils de Lyon·LYON, France·Deadline Jul 31, 2029 · 996 days left·Open·Supplies·DPS

Registrieren zum Speichern Open documents

Structured notice only

Originaltitel der Bekanntmachung

France – Medicinal products for the blood and blood-forming organs – UNIHA Fourniture de Médicaments Dérivés du Sang, recombinants et issus de Thérapie Génique

30/100

Opportunity Score

Needs reviewMedium complexity

SuppliesDPSOpen

Warum diese Bewertung?

Chance

30 / 100

Komplexität

60 / 100

Risikofaktoren

No estimated value, award criteria, or detailed selection criteria are provided. This significantly increases uncertain...

Tenders must be in French; non-French speakers may face translation costs and risks.

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Eckdaten der Ausschreibung

Öffentlicher Auftraggeber: Hospices Civils de Lyon
Land: Frankreich
CPV: 33621000 - Medicinal products for the blood and blood-forming organs +1 weitere
Frist: Jul 31, 2029

Überblick

Moderate opportunity

Wichtige Fakten

Dynamic Purchasing System (DPS)
Supplies contract
1 lot
Duration 45 MONTH
Supply of blood-derived medicinal products, recombinant medicinal products, and gene therapy medicinal products.
Dynamic purchasing system (DPS) and framework agreement for a group of contracting authorities coordinated by Uni.H.A.

Vollständige Zusammenfassung anzeigen

This tender by Hospices Civils de Lyon (France) establishes a Dynamic Purchasing System (DPS) and framework agreement for blood-derived, recombinant, and gene therapy medicinal products. It covers a single lot with a 45-month duration. The deadline for submission is 31 July 2029. No estimated value is provided. Submission is electronic and must be in French. Selection criteria are vaguely defined as 'Critères Divers' (various criteria). Award criteria are absent from the provided data. The tender is open to SMEs and involves no EU funding.

Risiken

No estimated value, award criteria, or detailed selection criteria are provided. This significantly increases uncertain...

Tenders must be in French; non-French speakers may face translation costs and risks.

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

Must comply with Directive 2014/24/EU.

Administrative

Electronic submission via www.marches-publics.gouv.fr.
Tenders must be submitted in French.

Anforderungen können unvollständig sein.

Auftraggeber

Name

Hospices Civils de Lyon

Ort

LYON, FRA

E-Mail

[email protected]

Website

www.chu-lyon.fr

Auftraggeberprofil

Profil öffnen

Kennung

26690027300019

Tätigkeit

Health

Lose (1)

LOT-0001

UNIHA-Fourniture de Médicaments Dérivés du Sang, recombinants et issus de Thérapie Génique

Dynamic acquisition system for blood-derived medicinal products, including recombinant and gene therapy products, managed by the groupement de commandes Uni.H.A. Place of performance is France.

SuppliesDPSFrameworkEU fundedElectronic submissionSME suitable

Ort

France

Dauer

45 MONTH

Kategorie

Medicinal products for the blood

Frist

Deadline Jul 31, 2029

Vergabedetails

Veröffentlichungsdatum: 18 Nov 2025
Sprachen: French

Referenzmetadaten

Rechtsgrundlage: 32014L0024

Referenz-IDs

Ausschreibungs-ID: 766772-2025

Dokumente (1)

Vergabedokument 1